Abstract
Nonsteroidal anti-inflammatory drugs (NSAIDs) confer a gastrointestinal (GI) side effect profile and concerns regarding adverse cardiovascular effects have emerged associated with considerable morbidity and mortality. NSAIDs are highly effective in treating pain and inflammation, but it is well recognized that these agents are associated with substantial gastrointestinal toxicity. Cyclo-oxygenase-2 inhibitors may also reduce the risk for gastrointestinal events, although they may increase cardiovascular adverse events. The selection of an appropriate analgesic or antiinflammatory agent with or without gastroprotective therapy should be individualized.
Keywords
Publication details
- DOI
- 10.5001/omj.2011.101
- Journal
- Oman Medical Journal
- Publisher
- Oman Medical Specialty Board
- Open access
- Gold open access
Cite this article
APA 7
Al-Saeed, A. (2011). Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs. Oman Medical Journal. https://doi.org/10.5001/omj.2011.101
MLA 9
Al-Saeed, Abdulwahed. "Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs." Oman Medical Journal, 2011. https://doi.org/10.5001/omj.2011.101.
Chicago (author–date)
Al-Saeed, Abdulwahed. 2011. "Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs." Oman Medical Journal. https://doi.org/10.5001/omj.2011.101.
Harvard
Al-Saeed, A. (2011) 'Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs', Oman Medical Journal. doi:10.5001/omj.2011.101.
Vancouver
Al-Saeed A. Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs. Oman Medical Journal. 2011. doi:10.5001/omj.2011.101
IEEE
A. Al-Saeed, "Gastrointestinal and Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs," Oman Medical Journal, 2011, doi: 10.5001/omj.2011.101.